OTC · Drug Manufacturers - Specialty & Generic

Ayurcann Holdings Corp. (AYURF) Stock

$0.00 OTC: AYURF Healthcare

Ayurcann Holdings Corp. offers extensive outsourcing services to licensed cannabis producers throughout Canada, specializing in post-harvest operations.

Valuation

MetricValue
Price$0.00
Market Cap$58411
P/E Ratio
P/B Ratio
P/S Ratio0.00
EPS (TTM)$-0.02
52-Week High$0.03
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE150.00%
ROA-16.60%
ROCE50.00%
Gross Margin27.57%
Operating Margin-11.29%
Net Margin-13.88%
Debt/Equity-0.50
Current Ratio0.61

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$9.0M$12.0M$25.0M$31.0M
Operating Profit$2.0M$-3.0M$-5.0M$-3.0M$-3.0M
Net Profit$0$-3.0M$-5.0M$-4.0M$-3.0M
EPS$0.00$-0.03$-0.04$-0.02$-0.01
Op Margin28.3%-35.5%-42.8%-12.9%-9.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$7.0M$7.0M$13.0M$15.0M$9.0M
Total Liabilities$2.0M$2.0M$10.0M$14.0M$11.0M
Cash$1.0M$1.0M$1.0M$0$2.0M
Borrowings$0$0$0$1.0M$1.0M

Latest News

Red White & Bloom Brands' Unit Completes Ayurcann Buy MT Newswires · Jun 8, 2026 Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Completes Acquisition of Ayurcann's Health Canada-Licensed Manufacturing Operations, Leading Vape & Pre-Roll Brands, and Expanded National Distribution Capabilities GlobeNewswire · Jun 8, 2026 Red White & Bloom Brands’ Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group GlobeNewswire · Jun 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$2.0M
Investing Cash Flow$0$-1.0M$-1.0M$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$1.0M$0$-1.0M$1.0M
Free Cash Flow$-1.0M$0$-1.0M$-1.0M$2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA0.04
FCF Yield3424.01%
Quick Ratio0.38
Interest Coverage
Return 1Y
Return 3Y
Return 5Y

Ownership

Insiders Held65.64%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AYRWFAyr Wellness Inc. $0.00 -0.03 $467094 0.00%
BGXXBright Green Corporation $0.04 +5328.57% -0.52 $7.26M 0.00%
CBIHCannabis Bioscience International Holdings, Inc. $0.00 -0.01 $1.74M 0.00%
CLCFFChristina Lake Cannabis Corp. $0.02 +0.00% -2.27 $4.22M 0.00%
CRRTFCrescita Therapeutics, Inc. $0.56 +0.00% -43.17 $10.40M 0.00%

About Ayurcann Holdings Corp.

Ayurcann Holdings Corp. offers extensive outsourcing services to licensed cannabis producers throughout Canada, specializing in post-harvest operations. The company delivers a full suite of services, from initial extraction and refinement to the sale of bulk distillate oil. It also provides custom formulation for white-label manufacturing, manages fulfillment and distribution logistics, and supplies personalized packaging options along with inventory management. Beyond its B2B services, Ayurcann also produces various medicinal cannabis products, including tinctures, vapes, and topicals. Furthermore, it operates the Ayurcann marketplace, an online platform dedicated to medical cannabis consumers. The company was established in 2018 and has its headquarters in Pickering, Canada.

Ayurcann Holdings Corp. (AYURF) stock trades at $0.00 with a market capitalization of $58411. The stock is valued at price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.03, and currently trades 100.0% below its 52-week high.

On profitability, Ayurcann Holdings Corp. generates a return on equity (ROE) of 150.00% — well above the market average, a sign of a high-quality business, return on capital employed of 50.00%, an operating margin of -11.29%, a net profit margin of -13.88%.

Official website: ayurcann.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides